Risk factors for neonatal herpes simplex virus (HSV) infection associated with maternal herpes are prematurity, prolonged rupture of membranes (PROM), and primary as opposed to recurrent maternal infection.
Risk factors for neonatal herpes simplex virus (HSV) infection associated with maternal herpes are prematurity, prolonged rupture of membranes (PROM), and primary as opposed to recurrent maternal infection. 1 Infants born to primary infected mothers develop systemic HSV infection in up to 75% of cases. In contrast, newborns delivered to mothers with long-lasting infection are unlikely to be infected because the virus is transmitted in only 2% to 5% of cases of prepartum herpetic recurrence. Both the serological status of the mother and the titer of HSV antibodies at the time of birth are risk factors for neonatal infection. 1 Consequently, precise characterization of maternal immune status is needed. However, serological analyses carried out for establishing the diagnosis during the acute phase of the disease are often misleading. Cross-reactions with other viruses or vigorous nonspecific immune stimulations often result in spurious presence or increments of herpes-''specific'' IgM and IgG. Therefore, the diagnosis of HSV infection is usually based on the direct identification of the virus in clinical or autopsy specimens by culture and/or polymerase chain reaction (PCR) with variably delayed results.
For a variety of viral infections, the usefulness of measuring specific IgG avidity is recognized for distinguishing primary infection -with low specific IgG avidity -from past, long-lasting or recurrent infection, in which the increase in IgG avidity correlates with time after infection. 2 -9 Assessment of specific IgG avidity is especially reliable for dating the onset of infection with viruses such as rubella virus and cytomegalovirus (CMV) in pregnant women. 3, 8 For instance, pregnant women with CMV primary infection have a CMV-specific IgG avidity index (AI) <50%, whereas pregnant women with past or secondary CMV infection have a CMV-specific IgG AI >60%. 3 For HSVs, the clinical value of IgG antibody avidity measurements has also been established. 9, 10 In case of active diseases, AI measurements make clear whether symptoms are due to recurrences and reactivations or whether they result from primary infection. 10 We presently report two cases of perinatal HSV infection wherein the evaluation of neonatal herpetic infection transmitted from a primary infected mother was speeded up and secured by the measurement of HSV-specific IgG avidity.
CASE REPORTS
Patient 1 was a male full-term 7-day-old infant born by vaginal delivery and referred for fever persisting despite antibiotherapy. Four days after admission, the physical findings included hepatomegaly, jaundice, purpura, and oliguria. Laboratory findings were: platelets 27Â10 9 /l, fibrinogen 0.3 g/l, V factor <15%, D-dimers 7.5 g/ml, aspartate aminotransferase 9 380 U/l, alanine aminotransferase 2 940 U/l, C-reactive protein 48 mg/l. The suspected diagnosis of viral infection was strengthened by the retrospective notion of a febrile and fleeting vesicular eruption in the mother occurring 3 days after delivery and the detection of an increased interferon level (200 U/ml, normal <2) in the serum of the newborn. The baby was given intravenous acyclovir, polyvalent immunoglobulins, and three blood exchange transfusions, the third with hyperimmune serum obtained from the mother. He nevertheless died on day 15 without presenting any skin or mucous vesicular lesions. HSV was identified in the culture of fluid obtained from the mother's vesicles and HSV IgM antibodies were evidenced in the serum of the infant obtained 14 days after birth. Serologic testing performed on maternal serum 11 days after delivery revealed the presence of IgM antibodies specific for HSV, Classical serologic assays are not useful for the diagnosis of perinatal herpes simplex virus ( HSV ) infection during the acute phase of the disease. We report two cases of neonatal HSV infection that highlight the diagnostic value of HSV -specific IgG avidity and its contribution for further characterization of neonatal HSV infection. IgG titers are presented semiquantitatively according to each manufacturer's arbitrary units for HSV, EBV, CMV, and VZV and to international unit for rubella. HSV IgM titers were determined using Enzygnost antiHSV / IgM Dade Behring Marburg kit ( Marburg, Germany ). Assessment of IgG AI for rubella virus, VZV, CMV, and HSV was determined using Dade Behring kits as previously described. (Table 1) . IgG AI for HSV was 15% whereas IgG AI for rubella virus and EBV was 89% and 100%, respectively, proving primary HSV infection. Patient 2 was a female premature infant born by caesarian section at 26 weeks of gestational age after PROM. During the first days of life, this very premature infant had respiratory distress syndrome associated with ductus arteriosus patency. Ten days after birth, her respiratory status worsened with appearance of hepatomegaly, diffuse bleeding, and coma. Laboratory studies showed aspartate aminotransferase 3 712 U/l, alanine aminotransferase 365 U/l, hemoglobin 82 g/l, platelets 47Â10 9 /l, fibrinogen 0.4 g/l, coagulation factors <15%, V factor 4%, D-dimers 3 g/ml. Bacterial investigations were negative. The infant died from multiple-organ failure at the age of 11 days, despite aggressive treatment including blood, platelet, and plasma infusions. The interferon level in the neonate serum was >200 U/ml. HSV was identified in blood culture and HSV-2 DNA was detected by PCR in blood, urine, and tracheal aspiration fluid. A primary genital HSV-2 infection was considered in the mother, her partner having genital herpetic-like lesions several weeks before delivery. Again, IgM specific for HSV, EBV, and varicella zoster virus (VZV) were detected in the serum of the mother 11 days after delivery (Table 1) . IgG AI for HSV was 48% whereas IgG AI for rubella virus, EBV, and VZV was 77%, 92%, and 100%, respectively.
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DISCUSSION
Accurate diagnosis of primary HSV infection during the last weeks of pregnancy or immediately after delivery is important because primary as opposed to recurrent maternal herpetic infection is a high-risk factor for neonatal HSV infection. Infants born to primary infected mothers must be closely observed during the first weeks of life and prophylactic therapy may be considered in case of vaginal delivery or PROM. 1 The most definitive means for demonstrating the diagnosis of HSV infection in the neonate are isolation of the virus in tissue culture or detection of viral DNA using PCR. However, proper tissue samples for virus isolation or PCR amplification are not always available, especially because vesicular lesions are often absent or fleeting in both mother and neonate. Moreover, specimens are not always correctly processed and PCR inhibitors or antiviral treatment initiated before recovering tissue samples may interfere with this analysis.
Detection of ''specific'' HSV IgM has been proposed as a means of identifying primary infection. However, the usefulness of this testing remains controversial: IgM antibodies can persist over a long period and specific IgM response can be observed after reinfection, endogenous latent reactivation, or even during the course of other viral illnesses, as seen in our two observations. Indeed, in each of the mothers, specific IgM, associated with a high level of specific IgG, was detected for HSV as well as for EBV, rubella virus, and VZV during the acute phase of the newborn disease. In both mothers, the finding of a low IgG AI for HSV established at first the diagnosis of primary infection, lately confirmed by the demonstration of conversion for HSV antibody when retrospective analysis of earlier serum samples were carried out. In addition, the finding of a high IgG AI for EBV, rubella, or VZV infections indicated that the potentially misleading presence of specific IgM for these viruses was likely to be due to nonspecific polyclonal stimulation or cross-reaction. It highlights the value of AI to distinguish between genuine specific IgM increments, primary infection associated, and spurious IgM increments.
Our observations demonstrated that in such circumstances the determination of HSV-specific IgG AI is a valuable tool for establishing a fast and accurate evaluation of HSV infection in newborns delivered from acutely infected mothers.
